Showing results (1-10 of 162) with videos related to
Sort By:
Pageof 17
Current Opinion in Molecular Therapeutics|August 19, 2007
Treating HIV-1 infection with dendritic cellsNancy C Connolly, Bonnie A Colleton, Charles R RinaldoAIDS Reviews|November 24, 2005
Proinflammatory cytokines in HIV disease-a review and rationale for new therapeutic approachesNancy C Connolly, Sharon A Riddler, Charles R RinaldoClinical and Vaccine Immunology : CVI|November 3, 2006
CD27 and CD57 expression reveals atypical differentiation of human immunodeficiency virus type 1-specific memory CD8+ T cellsAki Hoji, Nancy C Connolly, William G Buchanan, et al.Journal of Virology|April 10, 2009
Primary human immunodeficiency virus type 1-specific CD8+ T-cell responses induced by myeloid dendritic cellsBonnie A Colleton, Xiao-Li Huang, Nada M Melhem, et al.Journal of Virology|February 15, 2005
Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected personsXiao-Li Huang, Zheng Fan, Bonnie A Colleton, et al.Virology|March 21, 2006
Minimization of genetic distances by the consensus, ancestral, and center-of-tree (COT) sequences for HIV-1 variants within an infected individual and the design of reagents to test immune reactivityGirish S Kesturu, Bonnie A Colleton, Yi Liu, et al.Virology|February 8, 2014
The impact of viral evolution and frequency of variant epitopes on primary and memory human immunodeficiency virus type 1-specific CD8⁺ T cell responsesNada M Melhem, Kellie N Smith, Xiao-Li Huang, et al.Clinical and Vaccine Immunology : CVI|October 19, 2007
Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individualsNancy C Connolly, Theresa L Whiteside, Cara Wilson, et al.Clinical and Vaccine Immunology : CVI|November 29, 2008
Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infectionTheresa L Whiteside, Paolo Piazza, Amanda Reiter, et al.American Journal of Public Health|April 28, 2005
Passive immunization against poliomyelitis: the Hammon gamma globulin field trials, 1951-1953Charles R RinaldoPageof 17